본문 바로가기
KERD
논문KCI 등재

Immunostimulatory Effects of Silica Nanoparticles in Human Monocytes

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Amorphous silica particles, whose applications are increasing in many biomedical fields, are known to be less toxic than crystalline silica. In this study, the inflammatory effects of amorphous silica nanoparticles were investigated using 30-nm amorphous silica nanoparticles and human peripheral blood mononuclear cells (PBMCs) or purified monocytes. As a result, production of IL-1β and IL-8 were increased. In addition, the mitochondrial reactive oxygen species (ROS) was detected, which may lead to mitochondrial membrane disruption. Most importantly, inflammasome formation was observed. Therefore, these results provide immunological information about amorphous silica nanoparticles and suggest that amorphous silica nanoparticles can evoke innate immune reactions in human monocytes through production of IL-1β and IL-8

Abstract

Amorphous silica particles, whose applications are increasing in many biomedical fields, are known to be less toxic than crystalline silica. In this study, the inflammatory effects of amorphous silica nanoparticles were investigated using 30-nm amorphous silica nanoparticles and human peripheral blood mononuclear cells (PBMCs) or purified monocytes. As a result, production of IL-1β and IL-8 were increased. In addition, the mitochondrial reactive oxygen species (ROS) was detected, which may lead to mitochondrial membrane disruption. Most importantly, inflammasome formation was observed. Therefore, these results provide immunological information about amorphous silica nanoparticles and suggest that amorphous silica nanoparticles can evoke innate immune reactions in human monocytes through production of IL-1β and IL-8

참고문헌 (29)

  1. Hirsch, L. R., "Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance", Proc. Natl. Acad. Sci. U. S. A, 100, pp.13549~13554 (2003)
  2. Bharali, D. J., "Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain", Proc. Natl. Acad. Sci. U. S. A, 102, pp.11539~11544 (2005)
  3. Roy, I., "Optical tracking of organically modified silica nanoparticles as DNA carriers: a nonviral, nanomedicine approach for gene delivery", Proc. Natl. Acad. Sci. U. S. A, 102, pp.279~284 (2005)
  4. Bottini, M., "Quantum dot-doped silica nanoparticles as probes for targeting of T-lymphocytes", Int. J. Nanomedicine, 2, pp.227~233 (2007)
  5. Verraedt, E., "Controlled release of chlorhexidine from amorphous microporous silica", J. Control. Release, 142, pp.47~52 (2010)
  6. Zhang, F. F., "Simultaneous assay of glucose, lactate, L-glutamate and hypoxanthine levels in a rat striatum using enzyme electrodes based on neutral red-doped silica nanoparticles", Anal. Bioanal. Chem, 380, pp.637~642 (2004)
  7. Santra, S., "Conjugation of biomolecules with luminophore-doped silica nanoparticles for photostable biomarkers", Anal. Chem, 73, pp.4988~4993 (2001)
  8. Gemeinhart, R. A., "Cellular fate of a modular DNA delivery system mediated by silica nanoparticles", Biotechnol. Prog, 21, pp.532~537 (2005)
  9. Slowing, I. I., "Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers", Adv. Drug Deliv. Rev, 60, pp.1278~1288 (2008)
  10. Maynard, A. D., "Safe handling of nanotechnology", Nature, 444, pp.267~269 (2006)
  11. Greenberg, M. I., "Silicosis: a review", Dis. Mon, 53, pp.394~416 (2007)
  12. Mossman, B. T., "Mechanisms in the pathogenesis of asbestosis and silicosis", Am. J. Respir. Crit. Care. Med, 157, pp.1666~1680 (1998)
  13. Huaux, F., "New developments in the understanding of immunology in silicosis", Curr. Opin. Allergy. Clin. Immunol, 7, pp.168~173 (2007)
  14. Yang, E. J., "Inflammasome formation and IL-1β release by human blood monocytes in response to silver nanoparticles", Biomaterials, 33, pp.6858~6867 (2012)
  15. Hornung, V., "Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization", Nat. Immunol, 9, pp.847~856 (2008)
  16. Dostert, C., "Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica", Science, 320, pp.674~677 (2008)
  17. Cassel, S. L., "The Nalp3 inflammasome is essential for the development of silicosis", Proc. Natl. Acad. Sci. U. S. A, 105, pp.9035~9040 (2008)
  18. Morishige, T., "The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1beta production, ROS production and endosomal rupture", Biomaterials, 31, pp.6833~6842 (2010)
  19. Winter, M., "Activation of the inflammasome by amorphous silica and TiO2 nanoparticles in murine dendritic cells", Nanotoxicology, 5, pp.326~340 (2011)
  20. Yazdi, A. S., "Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β", Proc. Natl. Acad. Sci. U. S. A, 107, pp.19449~19454 (2010)
  21. Jin, C, "Molecular mechanism of NLRP3 inflammasome activation", J. Clin. Immunol, 30, pp.628~631 (2010)
  22. Netea, M. G., "Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages", Blood, 113, pp.2324~2335 (2009)
  23. Landmesser, U., "Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension", J. Clin. Invest, 111, pp.1201~1209 (2003)
  24. Sevier, C. S., "Ero1 and redox homeostasis in the endoplasmic reticulum", Biochim. Biophys. Acta, 1783, pp.549~556 (2008)
  25. Sorbara, M. T., "Mitochondrial ROS fuel the inflammasome", Cell Res, 21, pp.558~560 (2011)
  26. Shukla, R. K., "Titanium dioxide nanoparticles induce oxidative stress-mediated apoptosis in human keratinocyte cells", J. Biomed. Nanotechnol, 7, pp.100~101 (2011)
  27. Ahmad, J., "Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2", Toxicol. Appl. Pharmacol, 259, pp.160~168 (2012)
  28. Bulua, A. C., "Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)", J. Exp. Med, 208, pp.519~533 (2011)
  29. Arnoult, D., "Mitochondria in innate immunity", EMBO Rep, 12, pp.901~910 (2011)

관련 논문AI추천

이 간행물의 다른 논문 (4건)